Skip to content
Health · World
FDA issues new warning regarding potential vision risks linked to GLP-1 drugs
4 sourcesFirst reported 5 days agoUpdated 5 days ago
Untold
No right-leaning outlet covered this story. You are only seeing one side of the political spectrum.
Left 50%
Center 50%
2 left-leaning2 center
No right-leaning outlets covered this story. Coverage comes exclusively from centrist or left-leaning sources. Right-leaning media may not consider the story significant, or it challenges conservative narratives. Seek out right-leaning commentary to complete the picture.
Who reported first
EthnosFirst
Ethnos+15h
Sigmalive+16h
Ars Technica+18h
All coverage
left
Ozempic, Wegovy, Zepbound και Mounjaro: Νέα προειδοποίηση του FDA για πιθανό κίνδυνο στην όραση
Ethnos· 5 days ago
left
Ozempic και Wegovy: Νέα προειδοποίηση του FDA για πιθανό κίνδυνο απώλειας όρασης
Ethnos· 5 days ago
center
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
Ars Technica· 5 days ago
center
Ozempic και Wegovy: Προειδοποίηση του FDA για πιθανό κίνδυνο απώλειας όρασης
Sigmalive· 5 days ago